Clinical significance of miR-34a expression in thyroid diseases – an ¹⁸F-FDG PET-CT study

References

• CarneiroRMCarneiroBAAgulnikMKoppPAGilesFJTargeted therapies in advanced differentiated thyroid cancerCancer Treat Rev201541869069826105190
   PubMed Web of Science ®Google Scholar
• VucemiloLZnaorTKulisTSekerijaMZnaorAThyroid cancer incidence and mortality trends in Croatia 1988-2010Acta Clin Croat2015541303726058240
   PubMed Web of Science ®Google Scholar
• MorrisLGSikoraAGTostesonTDDaviesLThe increasing incidence of thyroid cancer: the influence of access to careThyroid201323788589123517343
   PubMed Web of Science ®Google Scholar
• VeigaLHNetaGAschebrook-KilfoyBRonEDevesaSSThyroid cancer incidence patterns in Sao Paulo, Brazil, and the U.S. SEER program, 1997–2008Thyroid201323674875723410185
   PubMed Web of Science ®Google Scholar
• MitroSDRozekLSVatanasaptPIodine deficiency and thyroid cancer trends in three regions of Thailand, 1990–2009Cancer Epidemiol2016438929927420631
   PubMed Web of Science ®Google Scholar
• ZhengXWeiSHanYPapillary microcarcinoma of the thyroid: clinical characteristics and BRAF(V600E) mutational status of 977 casesAnn Surg Oncol20132072266227323370668
   PubMed Web of Science ®Google Scholar
• LeeMJHongSWChungWYKwakJYKimMJKimEKCytological results of ultrasound-guided fine-needle aspiration cytology for thyroid nodules: emphasis on correlation with sonographic findingsYonsei Med J201152583884421786450
   PubMed Web of Science ®Google Scholar
• Alvarez-GarciaIMiskaEAMicroRNA functions in animal development and human diseaseDevelopment2005132214653466216224045
   PubMed Web of Science ®Google Scholar
• MaroniPPuglisiRMattiaGIn bone metastasis miR-34a-5p absence inversely correlates with Met expression, while Met oncogene is unaffected by miR-34a-5p in non-metastatic and metastatic breast carcinomasCarcinogenesis201738549250328334277
   PubMed Web of Science ®Google Scholar
• WangYChenJChenXMiR-34a suppresses HNSCC growth through modulating cell cycle arrest and senescenceNeoplasma201764454355328485160
   PubMed Web of Science ®Google Scholar
• ZhouYHuangTSiuHLIGF2BP3 functions as a potential oncogene and is a crucial target of miR-34a in gastric carcinogenesisMol Cancer20171617728399871
   PubMed Web of Science ®Google Scholar
• PuYZhaoFWangHCaiSMiR-34a-5p promotes multi-chemoresistance of osteosarcoma through down-regulation of the DLL1 geneSci Rep2017734421828281638
   PubMed Web of Science ®Google Scholar
• YanKGaoJYangTMicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivoPLoS One201273e3377822457788
   PubMed Web of Science ®Google Scholar
• Di MartinoMTLeoneEAmodioNSynthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidenceClin Cancer Res201218226260627023035210
   PubMed Web of Science ®Google Scholar
• CaiHZhouHMiaoYLiNZhaoLJiaLMiRNA expression profiles reveal the involvement of miR-26a, miR-548l and miR-34a in hepatocellular carcinoma progression through regulation of ST3GAL5Lab Invest201797553054228218742
   PubMed Web of Science ®Google Scholar
• SunTYXieHJLiZmiR-34a regulates HDAC1 expression to affect the proliferation and apoptosis of hepatocellular carcinomaAm J Trans Res201791103114
   Web of Science ®Google Scholar
• PramanikDCampbellNRKarikariCRestitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in miceMol Cancer Ther20111081470148021622730
   PubMed Web of Science ®Google Scholar
• YamazakiHChijiwaTInoueYOverexpression of the miR-34 family suppresses invasive growth of malignant melanoma with the wild-type p53 geneExp Ther Med20123579379622969970
   PubMed Web of Science ®Google Scholar
• SunCWangFJZhangHGmiR-34a mediates oxaliplatin resistance of colorectal cancer cells by inhibiting macroautophagy via transforming growth factor-beta/Smad4 pathwayWorld J Gastroenterol201723101816182728348487
   PubMed Web of Science ®Google Scholar
• DaugaardIKnudsenAKjeldsenTEHagerHHansenLLThe association between miR-34 dysregulation and distant metastases formation in lung adenocarcinomaExp Mol Pathol2017102348449128512015
   PubMed Web of Science ®Google Scholar
• LiuLRenWChenKMiR-34a promotes apoptosis and inhibits autophagy by targeting HMGB1 in acute myeloid leukemia cellsCell Physiol Biochem20174151981199228478444
   PubMedGoogle Scholar
• FritzHKGustafssonALjungbergBCederYAxelsonHDahlbackBThe Axl-regulating tumor suppressor miR-34a is increased in ccRCC but does not correlate with Axl mRNA or Axl protein levelsPLoS One2015108e013599126287733
   PubMed Web of Science ®Google Scholar
• ChandrasekaranKSSathyanarayananAKarunagaranDDownregulation of HMGB1 by miR-34a is sufficient to suppress proliferation, migration and invasion of human cervical and colorectal cancer cellsTumour Biol20163710131551316627456356
   PubMedGoogle Scholar
• WenDPengYLinFSinghRKMahatoRIMicellar delivery of miR-34a modulator rubone and paclitaxel in resistant prostate cancerCancer Res201777123244325428428276
   PubMed Web of Science ®Google Scholar
• MaYQinHCuiYMiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathwayBiochem Biophys Res Commun2013441495896324220341
   PubMed Web of Science ®Google Scholar
• LuXChenZLiangHThyroid hormone inhibits TGFbeta1 induced renal tubular epithelial to mesenchymal transition by increasing miR34a expressionCell Signal201325101949195423770290
   PubMed Web of Science ®Google Scholar
• SachpekidisCDettmerMSWeidnerSGigerRWartenbergJ18F-FDG PET/CT of papillary carcinoma in a lateral thyroglossal duct cystClin Nucl Med2017428e371e37428525461
   PubMed Web of Science ®Google Scholar
• VeraPEdet-SansonAQuieffinFDiffusion-weighted MRI is not superior to FDG-PET/CT for the detection of neck recurrence in well-differentiated thyroid carcinomaQ J Nucl Med Mol Imaging201733
   Web of Science ®Google Scholar
• ChoiEKChongAHaJMJungCKOJHKimSHClinicopathological characteristics including BRAF V600E mutation status and PET/CT findings in papillary thyroid carcinomaClin Endocrinol20178717379
   Web of Science ®Google Scholar
• KongLZhuJHanWSignificance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical studyActa Diabetol2011481616920857148
   PubMed Web of Science ®Google Scholar
• NagarajanADograSKSunLParaoxonase 2 facilitates pancreatic cancer growth and metastasis by stimulating GLUT1-mediated glucose transportMol Cell2017674685.e6701.e628803777
   PubMed Web of Science ®Google Scholar
• WangJYeCChenCGlucose transporter GLUT1 expression and clinical outcome in solid tumors: a systematic review and meta-analysisOncotarget2017810168751688628187435
   PubMedGoogle Scholar
• AminMBGreeneFLEdgeSBThe Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer stagingCA Cancer J Clin2017672939928094848
   PubMed Web of Science ®Google Scholar
• ShahBRGriffithsRHallSFThyroid cancer incidence among Asian immigrants to Ontario, Canada: a population-based cohort studyCancer2017123173320332528440952
   PubMed Web of Science ®Google Scholar
• FallahiPFerrariSMRuffilliIIncidence of thyroid disorders in mixed cryoglobulinemia: results from a longitudinal follow-upAutoimmunity Rev201615774775126970485
   PubMed Web of Science ®Google Scholar
• O’GradyTJGatesMABoscoeFPThyroid cancer incidence attributable to overdiagnosis in the United States 1981-2011Int J Cancer2015137112664267326069163
   PubMed Web of Science ®Google Scholar
• La VecchiaCMalvezziMBosettiCThyroid cancer mortality and incidence: a global overviewInt J Cancer201513692187219525284703
   PubMed Web of Science ®Google Scholar
• GharibHFine-needle aspiration biopsy of thyroid nodules: advantages, limitations, and effectMayo Clin Proc199469144498271850
   PubMed Web of Science ®Google Scholar
• RumyantsevPOSaenkoVAIlyinAARadiation exposure does not significantly contribute to the risk of recurrence of Chernobyl thyroid cancerJ Clin Endocrinol Metab201196238539321084394
   PubMed Web of Science ®Google Scholar
• MissoGDi MartinoMTDe RosaGMir-34: a new weapon against cancer?Mol Ther Nucl Acids20143e194
   Google Scholar
• CahillSSmythPFinnSPEffect of ret/PTC 1 rearrangement on transcription and post-transcriptional regulation in a papillary thyroid carcinoma modelMol Cancer200657017156473
   PubMed Web of Science ®Google Scholar
• SheuSYGrabellusFSchwertheimSWormKBroecker-PreussMSchmidKWDifferential miRNA expression profiles in variants of papillary thyroid carcinoma and encapsulated follicular thyroid tumoursBr J Cancer2010102237638220029416
   PubMed Web of Science ®Google Scholar
• YangL-JWangD-GChenJ-YZhangH-YZhangF-FMouY-HExpression of miR-34a and its role in human papillary thyroid carcinomaInt J Clin Exp Pathol201710332583264
   Web of Science ®Google Scholar
• BignerDDBignerSHPontenJHeterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomasJ Neuropathol Exp Neurol19814032012296260907
   PubMed Web of Science ®Google Scholar
• CongDHeMChenSLiuXLiuXSunHExpression profiles of pivotal microRNAs and targets in thyroid papillary carcinoma: an analysis of The Cancer Genome AtlasOnco Targets Ther201582271227726345235
   PubMed Web of Science ®Google Scholar
• DalgardCLGonzalezMdeNiroJEO’BrienJMDifferential microRNA-34a expression and tumor suppressor function in retinoblastoma cellsInvest Ophthalmol Visual Sci200950104542455119443717
   PubMed Web of Science ®Google Scholar
• LodyginDTarasovVEpanchintsevAInactivation of miR-34a by aberrant CpG methylation in multiple types of cancerCell Cycle20087162591260018719384
   PubMed Web of Science ®Google Scholar
• American Academy of PediatricsOn the origin of cancer cellsPediatrics1956175746
   Google Scholar
• YunMNohT-WChoAVisually discernible [18F] fluorodeoxyglucose uptake in papillary thyroid microcarcinoma: a potential new risk factorJ Clin Endocrinol Metab20109573182318820427505
   PubMed Web of Science ®Google Scholar
• JeongHSChungMBaekCHKoYHChoiJYSonYICan [18F] – fluorodeoxyglucose standardized uptake values of PET imaging predict pathologic extrathyroid invasion of thyroid papillary microcarcinomas?Laryngoscope2006116122133213717146385
   PubMed Web of Science ®Google Scholar
• HoriuchiCTsukudaMTaguchiTIshiguroYOkuderaKInoueTCorrelation between FDG-PET findings and GLUT1 expression in salivary gland pleomorphic adenomasAnn Nucl Med200822869369818982472
   PubMed Web of Science ®Google Scholar
• WangZGYuMMHanYCorrelation of Glut-1 and Glut-3 expression with F-18 FDG uptake in pulmonary inflammatory lesionsMedicine (Baltimore)20169548e546227902598
   PubMed Web of Science ®Google Scholar